Delivery Order SPE2DB24D3013-SPE2DB25FFNZG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of FOTIVDA 0.89 mg capsules (21 count), with a ceiling value of $32,270.40 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp for Fotivda 1.34 mg capsules (21-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The contract, valued at $15,420.59, is for the delivery of FOTIVDA 1.34 MG CAPSULE 21S pharmaceutical products to Conshohocken, Pennsylvania. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FOTIVDA 0.89 MG CAPSULE 21S. The contract has a firm fixed price of $16,135.20 and a period of performance extending to July 3, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a...
- The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to AmerisourceBergen Drug Corporation for the supply of 21 capsules of the pharmaceutical FOTIVDA at 0.89 mg each. Valued at $15,596.18 with a firm fixed price, the order is to be performed in Conshohocken, Pennsylvania between August 22nd and September 13th, 2023. As a major provider of medical supplies and pharmaceuticals to the U.S. military, this order for cancer treatment medication supports the...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is valued at $32,652.72 and has a period of performance through March 18, 2024. It is for the provision of FOTIVDA 0.89 MG CAPSULE 21S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $31,192.36, is for the supply of the pharmaceutical product FOTIVDA 0.89 MG CAPSULE 21S. As a prime contractor, Amerisourcebergen Drug Corp has provided a range of pharmaceutical and medical products to support DLA Troop Support Medical programs and facilities. The contract has a completion date of January...
- The Defense Logistics Agency awarded a Delivery Order (4569006087) valued at $8,888.50 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with a completion date of August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. The company serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $15,596.18 to Amerisourcebergen Drug Corporation for the supply of 21 capsules of Fotivda, an oncology drug used to treat renal cell carcinoma. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania within the period of performance of June 27, 2023 through July 19, 2023. The firm fixed price contract was awarded utilizing Amerisourcebergen's position on an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,777.70 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Enhertu 100 mg vials, a specialized pharmaceutical product. The contract is firm fixed price with an ultimate completion date of August 11, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award is a non-set-aside competitive procurement, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNZGDelivery Order
The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp for FOTIVDA 1.34 mg capsule supply (21-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract is not set-aside and represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the major pharmaceutical distributor maintains its headquarters and operations center. This delivery order is part of AmerisourceBergen's broader pharmaceutical supply relationship with the Defense Logistics Agency, which leverages the company's comprehensive capability to deliver brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. As a prime contractor on the DLA's global pharmaceutical support vehicle, AmerisourceBergen serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current award demonstrates the company's ongoing role in fulfilling specialized pharmaceutical procurement requirements through the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 8/4/25 |